TXN

Texas Instruments Inc. TXN logo
NASDAQ Technology
$190.23
+4.22 (+2.26%)
Updated: 3/31/2026, 4:00:01 PM
Open
$190.28
High
$191.38
Low
$185.75
Prev Close
$186.42
Volume
1.19M

Price History

Why Is TXN ▲ Up Today?

+2.26%

Full AI analysis generates after market close. Showing live price data.

Financial Highlights

TTM 2025

Income Statement

Revenue
$17.68B
Gross Profit
$10.08B
57.0% margin
Operating Income
$6.02B
34.1% margin
Net Income
$5.00B
28.3% margin
EPS (Diluted)
$5.45
R&D Spend
$2.08B

Balance Sheet

Total Assets
$34.59B
Total Liabilities
$18.31B
Stockholders' Equity
$16.27B
Long-Term Debt
$14.05B

Cash Flow

Operating Cash Flow
$7.15B
Investing Activities
-$1.44B
Net Cash Flow
$25.0M

SEC filing dated February 6, 2026. Source: Polygon.io / SEC EDGAR.

Highly Regarded Analysis

Updated Apr 10, 2026 • Refreshes daily
Rating
HODL
Risk
Medium
Target
$216.07
Type
Standard

Executive Summary

Texas Instruments (TXN) is a leading semiconductor company, known for analog chips and microcontrollers. While the company shows strong financial health, analyst ratings are mixed, with a consensus 'Hold' rating. Recent market dynamics and internal factors contribute to a balanced outlook.

Bull Case

Texas Instruments is experiencing business momentum in its core Industrial and Automotive segments. The company's strategic acquisitions, growth in AI data centers, and transition to internal 300mm wafer manufacturing support a positive outlook. Analyst upgrades and broad industry optimism could serve as catalysts.

Bear Case

Analysts have concerns regarding TXN's capital allocation and capacity expansion strategy, which may pressure future margins and earnings. A slower recovery in the semiconductor industry, along with potential declines in China's automotive sales and conservative capital expenditure plans, pose risks.

Technical Outlook

TXN's technical indicators present a neutral outlook. The MACD indicates a neutral signal, RSI suggests a neutral condition, and Williams %R indicates an oversold condition. Monitor closely.

Fundamental Health

TXN exhibits strong profitability with high ROA, ROE, and ROIC compared to its industry peers. The company maintains a healthy current ratio and manageable debt levels, reflecting strong liquidity.

Key Catalysts

  • Automotive semiconductor expansion
  • AI data center growth
  • 300mm wafer transition

This analysis was conducted by Highly Regarded's proprietary market analysis engine. It is not financial advice. Always do your own research and consult a financial advisor before making investment decisions.

Key Stats

P/E Ratio 34.9x
EPS (Diluted) $5.45
Gross Margin 57.0%
Operating Margin 34.1%
Net Margin 28.3%
Revenue (Qtr) $17.68B
Shares Outstanding 908M
As of TTM 2025

Next Earnings

Date Apr 21, 2026
Time After Close
Quarter Q1 2026

TXN News

No recent news for TXN.